Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
J. Peter Figueroa,Maria Elena Bottazzi,Peter J. Hotez,Carolina Batista,Onder Ergonul,Sarah C. Gilbert,Mayda Gursel,Mazen Hassanain,Jerome H. Kim,Bhavna Lall,Heidi J. Larson,Denise Naniche,Timothy P. Sheahan,Shmuel Shoham,Annelies Wilder-Smith,Natalie Strub-Wourgaft,Prashant Yadav,Gagandeep Kang +17 more
Reads0
Chats0
TLDR
The COVAX Facility of the ACT Accelerator has agreements to access 2 billion doses of WHO prequalified vaccines during 2021, but this represents only 20% of the vaccine needs of participating countries Most low-income and middle-income countries face difficulties in accessing and delivering vaccines and therapeutics for COVID-19 to their populations.About:
This article is published in The Lancet.The article was published on 2021-02-13 and is currently open access. It has received 98 citations till now.read more
Citations
More filters
Journal ArticleDOI
The impact of COVID-19 on essential health service provision for endemic infectious diseases in the South-East Asia region: A systematic review
TL;DR: In this article , the authors conducted a systematic literature review of quantitative evidence to estimate the impact of COVID-19 on the provision of essential prevention, detection, treatment, and management services for five high-burden infectious diseases across the SEAR.
Journal ArticleDOI
Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico
Diego López-Mena,Miguel García-Grimshaw,S. Saldívar-Dávila,Laura E. Hernández-Vanegas,María M. Saniger-Alba,Alonso Gutierrez-Romero,Roger Carrillo-Mezo,Héctor E. Valdéz-Ruvalcaba,Vanessa Cano-Nigenda,Fernando Flores-Silva,Carlos Cantú-Brito,Ana María Santibáñez-Copado,José Luis Díaz-Ortega,Santa Elizabeth Ceballos-Liceaga,Luis Manuel Murillo-Bonilla,Ana Sepúlveda-Núñez,Verónica Garcí-A-Talavera,Eduardo Gonzalez-Guerra,Ricardo Cortes-Alcala,Hugo López-Gatell,G. Carbajal-Sandoval,Gustavo Reyes-Terán,Sergio I. Valdés-Ferrer,Antonio Arauz +23 more
TL;DR:
Peer ReviewDOI
Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis
Ezekiel Boro,Beat Stoll +1 more
TL;DR: The review revealed that barriers to COVID-19 health products were commonly caused by market forces, the unavailability, inaccessibility, and unaffordability of the products, incongruent donors' agenda and funding, and unreliable health and supply systems.
Journal ArticleDOI
How prepared is Mozambique to treat COVID-19 patients? A new approach for estimating oxygen service availability, oxygen treatment capacity, and population access to oxygen-ready treatment facilities.
Langan Denhard,Parisa Kaviany,Sérgio Chicumbe,Cláudio Muianga,Guitunga Laisse,Kyle T. Aune,Ashley Sheffel +6 more
TL;DR: The Mozambican health system faces the dual challenges of under-resourced health facilities and low geographic accessibility to healthcare as it prepares to confront the COVID-19 pandemic.
Journal ArticleDOI
SARS-CoV-2 infection in children and implications for vaccination
TL;DR: In this article , a review explores the current state of knowledge on COVID-19 in children including COVID19 vaccination strategies, and explores the indirect impacts of prolonged community and school closures on childhood education, social and behavioural development and mental health.
References
More filters
Journal ArticleDOI
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
Anthony D. So,Joshua Woo +1 more
TL;DR: This study provides an overview of how high income countries have secured future supplies of covid-19 vaccines but that access for the rest of the world is uncertain.
Journal ArticleDOI
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
Janet Sultana,Giampiero Mazzaglia,Nicoletta Luxi,Antonino Cancellieri,Annalisa Capuano,Carmen Ferrajolo,Chiara de Waure,Guido Ferlazzo,Gianluca Trifirò +8 more
TL;DR: This review will discuss the available immunologic and clinical evidence to support the benefit of the influenza, pneumococcal, and tuberculosis vaccines in the context of COVID-19 as well as to provide an overview on the CO VID-19-specific vaccines that are in the development pipeline.
Journal ArticleDOI
Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.
M. Teresa Aguado,Jane Barratt,John R. Beard,Bonnie B. Blomberg,Wilbur H. Chen,Julian Hickling,Terri B. Hyde,Mark Jit,Mark Jit,Rebecca Jones,Gregory A. Poland,Martin Friede,Justin R. Ortiz +12 more
TL;DR: There is a need for discussion of new opportunities for vaccinations of all adults as well as for vaccination of older adults, as reflected in the recent shift by WHO to a life-course approach to immunization.
Journal ArticleDOI
Strengthening medical product regulation in low- and middle-income countries.
TL;DR: Charles Preston and colleagues use case studies to describe how regulatory systems for medical products and medicines must be strengthened in low and middle income countries to assure adequate quality, safety and efficacy.
Related Papers (5)
The need for COVID-19 research in low- and middle-income countries
Madhu Gupta,Brian Wahl,Binita Adhikari,Binita Adhikari,Naor Bar-Zeev,Sudip Bhandari,Alexandra Coria,Daniel J. Erchick,Nidhi Gupta,Shreya Hariyani,E Wangeci Kagucia,Japhet Killewo,Rupali J. Limaye,Eric D. McCollum,Raghukul Pandey,William Pomat,Krishna D. Rao,Mathuram Santosham,Molly Sauer,Rhoda K. Wanyenze,David H. Peters +20 more